A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.
This study has been completed.
First Posted: September 15, 2009
Last Update Posted: March 20, 2014
Information provided by (Responsible Party):